Molecular Sub-Typing and Exploration of Key Signalling Pathways Involved in Complicating the Disease-Reference-Cited by-同舟云学术

Molecular Sub-Typing and Exploration of Key Signalling Pathways Involved in Complicating the Disease

Published:2023-01 Issue: Volume: Page:47-72
ISSN:
Container-title:Therapeutic Drug Targets and Phytomedicine For Triple Negative Breast Cancer
language:
Short-container-title:

Author:

Anto Nikhil Ponnoor¹,Muraleedharan Amitha²,Mittal Rashmi³

Affiliation:

1. University of the Negev,The Shraga Segal Dept. of Microbiology,Beer Sheva,Israel,

2. University of the Negev,Faculty of Health Sciences,,Beer Sheva,Israel,

3. Patanjali Research Institute,Patanjali Herbal Research Department,Haridwar,India,

Abstract

Triple-negative breast cancer is characterized by distinct molecular profiles, unique metastatic patterns, aggressive behavior, lacks the targeted therapeutic approach, and caused significant mortality worldwide. The molecular complexity of angiogenesis, autophagy, apoptosis, and metastasis process in TNBC has fostered research efforts to unleash the molecular, pathological, and genetic drivers of their lethal cascade. This complex disease entity involves PI3k/Akt/mTOR, NF-kB, ERRs, and miRNA trafficking which has further worsened the clinical outcome. Due to their heterogeneous nature, none of the drugs were able to completely target the TNBC tumor spectrum. This chapter highlights the classification of TNBC on the basis of aberrated copy number, histology, proteomic, and mutational profiles to understand the aetiology of the disease. The identification of therapeutic vulnerabilities was also carried out by gaining insights into the above-mentioned signalling pathways and their role in further complicating the disease. <br>

Publisher

BENTHAM SCIENCE PUBLISHERS

Reference115 articles.

1. Perou C.M.; Sørlie T.; Eisen M.B.; van de Rijn M.; Jeffrey S.S.; Rees C.A.; Pollack J.R.; Ross D.T.; Johnsen H.; Akslen L.A.; Fluge Ø.; Pergamenschikov A.; Williams C.; Zhu S.X.; Lønning P.E.; Børresen-Dale A.L.; Brown P.O.; Botstein D.; Molecular portraits of human breast tumours. Nature 2000,406(6797),747-752

2. Lin N.U.; Vanderplas A.; Hughes M.E.; Theriault R.L.; Edge S.B.; Wong Y.N.; Blayney D.W.; Niland J.C.; Winer E.P.; Weeks J.C.; Clinicopathologic features, patterns of recurrence, and survival among women with triple-negative breast cancer in the National Comprehensive Cancer Network. Cancer 2012,118(22),5463-5472

3. Wang D.; Zhu K.; Tian J.; Li Z.; Du G.; Guo Q.; Wu T.; Li J.; Li, J. Clinicopathological and ultrasonic features of triple-negative breast cancers: A comparison with hormone receptor - Positive/human epidermal growth factor receptor2–negative breast cancers. Ultrasound Med Biol 2018,44(5),1124-1132

4. Namazi S.; Monabati A.; Ardeshir-Rouhani-Fard S.; Azarpira N.; Association of angiotensin I converting enzyme (insertion/deletion) and angiotensin II type 1 receptor (A1166C) polymorphisms with breast cancer prognostic factors in iranian population. Mol Carcinog 2010,49(12),1022-1030

5. Hudis C.A.; Gianni L.; Triple-negative breast cancer: an unmet medical need. Oncologist 2011,16(S1)(Suppl. 1),1-11

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tumor Suppressive Role of MicroRNAs in Triple Negative Breast Cancer;Current Pharmaceutical Design;2023-11